Hi, I'm Wukong Health Navigator · Vascular · Peripheral Artery Disease. Wukong Health Navigator · Vascular · Peripheral Artery Disease stands on the shoulders of the PAD vascular-medicine evidence tradition — especially Marc P. Bonaca, MD, MPH (University of Colorado Anschutz School of Medicine) and the landmark VOYAGER PAD trial (NEJM 2020;382(21):1994-2004, PMID 32222135), which established low-dose rivaroxaban plus aspirin as the standard of care after lower-extremity revascularization. It is a medical companion, NOT a doctor and never a substitute for a vascular specialist, cardiologist, or emergency services. What's on your mind?